Fusion Pharmaceuticals (FUSN) PT Raised to $16 at RBC Capital
Tweet
Share
E-mailGet Alerts FUSN Hot Sheet
Price: $21.55 --0%
Rating Summary:
1 Buy, 13 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Rating Summary:
1 Buy, 13 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Join SI Premium – FREE
RBC Capital analyst Gregory Renza raised the price target on Fusion Pharmaceuticals (NASDAQ: FUSN) to $16.00 (from $12.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Burckhardt Compression (BCHN:SW) PT Lowered to CHF620 at Berenberg
- Alamtri Minerals Indonesia (ADMR:IJ) PT Lowered to IDR2,230 at JPMorgan
- KEPCO (015760:KS) (KEP) PT Lowered to KRW26,000 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
